All Outputs (3)

24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation (2014)
Journal Article
Lancaster, S. T., Blackburn, J., Blom, A., Makishima, M., Ishizawa, M., & Mansell, J. (2014). 24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation. Steroids, 83, 52-61. https://doi.org/10.1016/j.steroids.2014.01.010

Vitamin D receptor (VDR) agonists supporting human osteoblast (hOB) differentiation in the absence of bone resorption are attractive agents in a bone regenerative setting. One potential candidate fulfilling these roles is 24,25-dihydroxy vitamin D3 (... Read More about 24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation.

Convergence of vitamin D and lysophosphatidic acid signaling in stimulating human osteoblast maturation (2014)
Journal Article
Mansell, J. P., & Mansell, J. (2014). Convergence of vitamin D and lysophosphatidic acid signaling in stimulating human osteoblast maturation. Frontiers in Physiology, 5 JUL, https://doi.org/10.3389/fphys.2014.00263

N/A

Human osteoblast growth and maturation in response to metformin and the thienopyridone, A769662 (2014)
Journal Article
Blackburn, J., Burston, B., Shepherd, S., Bone, H., Blom, A., & Mansell, J. (2014). Human osteoblast growth and maturation in response to metformin and the thienopyridone, A769662

Metformin (Met) is a biguanide drug widely used in the treatment and management of non insulin-dependent diabetes mellitus. In recent years it has emerged that Met, by stimulating adenosine monophosphate-activated protein kinase (AMPK), can promote t... Read More about Human osteoblast growth and maturation in response to metformin and the thienopyridone, A769662.